Previous Article | Next Article 
Journal of Clinical Microbiology, October 2001, p. 3775-3777, Vol. 39, No. 10
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3775-3777.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Low Concentrations of Mupirocin in the Pharynx
following Intranasal Application May Contribute to Mupirocin Resistance
in Methicillin-Resistant Staphylococcus aureus
Hiroshi
Watanabe,1,*
Hironori
Masaki,1
Norichika
Asoh,1
Kiwao
Watanabe,1
Kazunori
Oishi,1
Shinobu
Kobayashi,2
Akiyoshi
Sato,3
Rinya
Sugita,4 and
Tsuyoshi
Nagatake1
Department of Internal Medicine, Institute of
Tropical Medicine, Nagasaki University,1 and
Departments of Internal Medicine2 and
Microbiology,3 Kyorin Hospital,
Nagasaki, and Sugita Otorhinolaryngologic Clinic,
Chiba,4 Japan
Received 21 May 2001/Returned for modification 11 July
2001/Accepted 24 July 2001
We describe a patient with methicillin-resistant
Staphylococcus aureus (MRSA) colonizing the pharynx. The
MIC of mupirocin was 0.25 µg/ml before treatment and increased after
treatment to 8 µg/ml. Using pulsed-field gel electrophoresis, we
confirmed that the genotypes of MRSA that colonized the pharynx
before and after the use of mupirocin were identical. We measured the
delivery of mupirocin to the pharynx in three normal volunteers and two patients. Low concentrations of mupirocin were present in the pharynx
in all cases 10 min to 3 days after intranasal application. Our data
suggested that low concentrations of the drug in the pharynx
after intranasal application of mupirocin ointment might explain
the selection of mupirocin resistance in MRSA.
*
Corresponding author. Mailing address: Department of
Internal Medicine, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. Phone: 81 (95) 849-7842. Fax: 81 (95) 849-7843. E-mail:
h-wata{at}net.nagasaki-u.ac.jp.
Journal of Clinical Microbiology, October 2001, p. 3775-3777, Vol. 39, No. 10
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3775-3777.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nilsson, P., Ripa, T.
(2006). Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares.. J. Clin. Microbiol.
44: 3334-3339
[Abstract]
[Full Text]
-
Hurdle, J. G., O'Neill, A. J., Chopra, I.
(2005). Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents. Antimicrob. Agents Chemother.
49: 4821-4833
[Full Text]
-
Critchley, I. A., Young, C. L., Stone, K. C., Ochsner, U. A., Guiles, J., Tarasow, T., Janjic, N.
(2005). Antibacterial Activity of REP8839, a New Antibiotic for Topical Use. Antimicrob. Agents Chemother.
49: 4247-4252
[Abstract]
[Full Text]
-
Ochsner, U. A., Young, C. L., Stone, K. C., Dean, F. B., Janjic, N., Critchley, I. A.
(2005). Mode of Action and Biochemical Characterization of REP8839, a Novel Inhibitor of Methionyl-tRNA Synthetase. Antimicrob. Agents Chemother.
49: 4253-4262
[Abstract]
[Full Text]
-
Rouse, M. S., Rotger, M., Piper, K. E., Steckelberg, J. M., Scholz, M., Andrews, J., Patel, R.
(2005). In Vitro and In Vivo Evaluations of the Activities of Lauric Acid Monoester Formulations against Staphylococcus aureus. Antimicrob. Agents Chemother.
49: 3187-3191
[Abstract]
[Full Text]
-
Wertheim, H. F. L., Verveer, J., Boelens, H. A. M., van Belkum, A., Verbrugh, H. A., Vos, M. C.
(2005). Effect of Mupirocin Treatment on Nasal, Pharyngeal, and Perineal Carriage of Staphylococcus aureus in Healthy Adults. Antimicrob. Agents Chemother.
49: 1465-1467
[Abstract]
[Full Text]
-
Hurdle, J. G., O'Neill, A. J., Ingham, E., Fishwick, C., Chopra, I.
(2004). Analysis of Mupirocin Resistance and Fitness in Staphylococcus aureus by Molecular Genetic and Structural Modeling Techniques. Antimicrob. Agents Chemother.
48: 4366-4376
[Abstract]
[Full Text]
-
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., Ljungh, A.
(2004). Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother
54: 648-653
[Abstract]
[Full Text]
-
Chaves, F., Garcia-Martinez, J., de Miguel, S., Otero, J. R.
(2004). Molecular Characterization of Resistance to Mupirocin in Methicillin-Susceptible and -Resistant Isolates of Staphylococcus aureus from Nasal Samples. J. Clin. Microbiol.
42: 822-824
[Abstract]
[Full Text]
-
Hurdle, J. G., O'Neill, A. J., Chopra, I.
(2004). The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden. J Antimicrob Chemother
53: 102-104
[Abstract]
[Full Text]
-
Kokai-Kun, J. F., Walsh, S. M., Chanturiya, T., Mond, J. J.
(2003). Lysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model. Antimicrob. Agents Chemother.
47: 1589-1597
[Abstract]
[Full Text]
-
Horii, T., Morita, M., Muramatsu, H., Muranaka, Y., Kanno, T., Maekawa, M.
(2003). Effects of mupirocin at subinhibitory concentrations on flagella formation in Pseudomonas aeruginosa and Proteus mirabilis. J Antimicrob Chemother
51: 1175-1179
[Abstract]
[Full Text]